Title : CD20-targeted T cells after stem cell transplantation for high risk and refractory non-Hodgkin's lymphoma.

Pub. Date : 2013 Jun

PMID : 23529012






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A phase I trial of infusing anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) armed activated T cells (aATC) was conducted in high-risk/refractory non-Hodgkin"s lymphoma patients to determine whether aATC infusions are safe, affect immune recovery, and induce an antilymphoma effect. aatc keratin 20 Homo sapiens